EMBLAVEO Design

View On IC.GC.CA

FORMALIZED

on 28 Aug 2023

Last Applicant/ Owned by

Allergan Pharmaceuticals International Limited

Clonshaugh Business and Technology ParkDublin 17D17 E400,

Serial Number

2277757 filed on 28^th Aug 2023

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

M5J2T3

EMBLAVEO Design

Trademark usage description

pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculos Read More

Vienna Information

17 . 2 . 1

Precious stonesPierres précieuses

17 . 2 . 2

Precious stones cut in facetsPierres précieuses taillées à facettes

24 . 17 . 20

Check signsCoches, signes de validation

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 5 . 1

One polygonUn polygone

26 . 5 . 10

Polygons containing one or more triangles or lines forming an anglePolygones contenant un ou plusieurs triangles ou des lignes formant un angle

26 . 5 . 16

Polygons containing other figurative elementsPolygones contenant d'autres éléments figuratifs

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

Classification Information

Class [005]
Pharmaceutical preparations to treat infections; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders.

Classification kind code

Mark Details

Serial Number

2277757

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 287 on 7^th Sept 2023	Pre-Assessment Letter Sent
Submitted for opposition 30 on 28^th Aug 2023	Filed
Submitted for opposition 1 on 28^th Aug 2023	Created
Submitted for opposition 31 on 28^th Aug 2023	Formalized